SANTA CLARA, Calif., May 8, 2018 – Elastifile, the enterprise hybrid cloud data management company, today announced that it will exhibit at Bio-IT World 2018 in booth No. 618 and present strategies for accelerating bioscience workflows through integration with the public cloud.
Elastifile delivers the compatibility, performance, scalability necessary to support the broad spectrum of bioscience workloads. Able to run seamlessly in the public cloud, on-premises, or spanning both, Elastifile’s cross-cloud data fabric is well-suited to support scientific organizations pursuing a variety of cloud integration strategies. Also, by supporting existing bioscience applications with a familiar file system interface, Elastifile enables those applications to run in-cloud without refactoring, thus eliminating a major roadblock to cloud adoption.
“Effective data management is crucial to effective Bio-IT, which then enables better, faster science,” said Jerome McFarland, VP of Marketing at Elastifile. “Unfortunately, traditional storage architectures have proven painfully ineffective at supporting cloud-integrated workflows. That’s where Elastifile comes in. We solve the data management challenges…unleashing the power of cloud-integrated bioscience.”
To further illustrate the value of cloud-integrated bioscience, Elastifile company executives will also deliver presentations in the Google Cloud booth (No. 410) detailing how Elastifile and Google Cloud Platform combine to deliver a powerful, full-stack Bio-IT solution.
Bio-IT World Conference & Expo, held May 15-17 at the Seaport World Trade Center in Boston, MA, is the premier event showcasing the myriad of IT and informatics applications and enabling technologies that drive biomedical research, drug discovery & development, and clinical and healthcare initiatives. More than 280 industry and academic colleagues will discuss themes of big data, smart data, cloud computing, trends in IT infrastructure, omics technologies, high-performance computing, data analytics, open source and precision medicine, from the research realm to the clinical arena.
Interested parties seeking a demonstration or an appointment with company executives should email firstname.lastname@example.org.